Ocugen

Ocugen Approaches Pivotal Juncture with Gene Therapy Pipeline

December 17, 2025

Ocugen Shares Face Mounting Technical and Regulatory Pressure

angelina - December 7, 2025

Ocugen Faces Mounting Financial Pressure as Cash Reserves Dwindle

November 13, 2025

Ocugen Shares Extend Decline Amid Mixed Financial Results

angelina - November 11, 2025

Ocugen’s Strategic Moves Position Biotech Firm for Critical Regulatory Phase

angelina - November 11, 2025

Ocugen’s Financial Crossroads: Balancing Innovation Against Mounting Pressures

November 10, 2025

Ocugen’s Financial Crossroads: Clinical Milestones Amid Mounting Losses

November 9, 2025

Ocugen’s Financial Crossroads: Strong Revenue Overshadowed by Mounting Losses

kashif hafeez - November 8, 2025

Ocugen Shares Tumble Despite Impressive Revenue Growth

angelina - November 7, 2025

All Eyes on Ocugen as Quarterly Results Approach

angelina - November 2, 2025

Ocugen’s Q3 2025 Report: A Pivotal Moment for Investors

angelina - October 31, 2025